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Abstract
 .One major problem in trans dermal drug delivery is the low penetration rate of drugs through the barrier of the skin.
Encapsulation of a drug in lipid vesicles is one strategy to increase the penetration rate of a drug across the skin. In this
study, the interactions between fluorescent-labelled liposomes and skin are visualized by confocal laser scanning
 .  .microscopy CLSM . Bilayer labelled gel-state and liquid-state liposomes conventional or with flexible bilayers were
non-occlusively applied on human skin in vitro. The penetration pathway and penetration depth of the lipophilic fluorescent
label into the skin were visualized. From the CLSM images, it was clear that the label applied in micelles and gel-state
liposomes did not penetrate as deep into the skin as the label applied in liquid-state vesicles. Among the liquid-state
vesicles, the suspensions with the flexible bilayers showed the highest fluorescence intensity in the dermis. Thus, the
thermodynamic state of the bilayer and, to a smaller extent, the flexibility of the bilayer influence, strongly the penetration
depth of the label into the skin. The label applied non-occlusively in flexible liposomes penetrated deeper into the skin than
after occlusive application. q 1998 Elsevier Science B.V.
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DLPC, 1,2-dilauroyl-sn-glycero-3-phosphatidylcholine; DSPC,
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.fluoresceinthiocarbamoyl -1,2-dihexadecanoyl-sn-glycero-3-
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 ..fluoresceinyl thiourea; C EO , heptaoxyethylenelaurylether;12 7
 .HEPES, 4- 2-hydroxyethyl -1-piperazine-ethane-sulphonic acid;
CHEMS, 5-cholesten-3b-ol 3-hemisuccinate; SC, stratum
corneum; E, epidermis; D, dermis
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1. Introduction
Human skin consists of an outer avascular strati-
fied squamous epidermis and an inner vascular der-
mis, which mainly consists of connective tissue and
contains nerves, hair follicles, sebaceous and sweat
glands. Basal layer cells of the epidermis differentiate
as they move towards the dermis and extrude lipids.
The cells cornify and loose their cell organelles and
get embedded in lipid lamellar sheets. This highly
organized structure becomes the outermost layer of
the skin and is also the main barrier of the skin, the
stratum corneum.
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One of the most encountered disadvantages in
 .trans dermal drug delivery is the low penetration
rate of most substances through the skin.
Various strategies have been developed to over-
come the skin barrier and to increase drug transport
across the skin. One method to increase the penetra-
tion rate of a drug across the skin, is encapsulation of
the drug in lipid vesicles. Mezei and Gulasekharam
w x1,2 were the first to report that liposomal triamci-
nolone acetonide facilitated the accumulation of the
drug within the epidermis and dermis. Although both
the experimental set-up and the interpretation of the
w xresults of this study have been criticized 3–5 , the
feasibility of an enhanced transdermal drug transport
by means of liposomes was recognised to be valid;
therefore, numerous studies were carried out, in which
vesicles were used to increase drug transport through
w xthe skin 5 . Methods for studying the skin–vesicle
w xinteractions are, e.g., diffusion experiments 6–8 ,
w xvisualization by electron microscopy 9–11 , and flu-
w xoro-micrography 12–14 . Fluoromicrographs of skin
treated with fluorescent-labelled liposomes demon-
strated that the fluorescent marker remained in the
w xstratum corneum 12,13 or penetrated deeper in the
w xepidermis predominantly along the hair-shafts 14 . A
disadvantage of the fluoromicrograph technique is
 .that the tissue needs to be cryo fixed, which may
change skin lipid organization or may result in redis-
w xtribution of the label 15 . The major advantage of
 .confocal laser scanning microscopy CLSM is that
the tissue can be optically sectioned, and that the
distribution of the fluorescent probe in the sample
can be visualized by images parallel to the surface of
the sample, without cryofixing or embedding the
tissue.
Until now, a few studies have been carried out
using CLSM to investigate the interactions between
vesicles and skin. It should be noted that CLSM does
not provide information about the permeation of the
entire liposome, but only about the penetration of the
w xfluorescent label. Zellmer et al. 16 applied non-oc-
clusively liposomes with a lipophilic fluorescent probe
on human mamma skin. After 18 h of application, the
skin was examined by CLSM, and the label could
only be detected on the surface of the skin. In another
w x w xstudy, Cevc et al. 17 and Schatzlein and Cevc 18¨
used fluorescent-labelled transfersomese and claimed
that the fluorescent marker could be visualized by
CLSM, until an apparent depth of 25 mm in murine
skin.
In the present study, the interactions between vari-
ous types of liposomes and human skin were investi-
 .gated, in vitro. A comparison was made i between
 .gel-state and liquid-state liposomes and ii between
several liquid-state suspensions, which varied in the
flexibility of their bilayer by incorporation of a
.surfactant . Micelles were used as a control formula-
tion. A lipophilic fluorescent dye was incorporated in
the bilayer of the vesicles, and the penetration path-
way and penetration depth of the phospholipid bound
label into the skin was examined by CLSM, after
various application periods. The treated skin was
visualized perpendicular to the skin surface, using
CLSM in combination with the cross-section device,
w xas described by Van Kuijk-Meuwissen et al. 19 .
This mechanical cross-section method has the advan-
tage to visualize fluorescence in the stratum corneum,
viable epidermis and dermis in a single image.
2. Materials and methods
2.1. Chemicals
1,2-Dilauroyl-sn-glycero-3-phosphatidylcholine
 .DLPC and 1,2-distearoyl-sn-glycero-3-phosphati-
 .dylcholine DSPC were gifts from Nattermann
 .Phospholipids Cologne, Germany . Heptaoxyeth-
 .ylenelaurylether C EO was purchased from12 7
 . Servo Delden, The Netherlands . N- 5-fluo-
.resceinthio-carbamoyl -1,2-dihexadecanoyl-sn-glyce-
 .ro-3-phosphoethanol-amine Fl-DHPE and N-oc-
X   ..  .tadecyl-N - 5- fluoresceinyl thiourea Fl-C were18
Table 1
The composition of the formulations used in this study
Formulation Composition Mean size
 .  .% molar ratio nm
 .C EO micelles 100 2412 7
DLPC:C EO 60:40 18012 7
DLPC:C EO 82:18 10812 7
DLPC:CHEMS 82:18 178
DSPC:CHEMS 82:18 228
The polydispersity indices of the formulations ranged between
0.25 and 0.35.
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 .both from Molecular Probes Eugene, OR, USA .
 . X N - 2 - h y d r o x y e t h y l p i p e r a z i n e - N - 2 -
.  .ethanesulfonicacid HEPES and cholesteryl-
 .hemisuccinate CHEMS were obtained from Sigma
 .Hilversum, The Netherlands and sodium chloride
 .was purchased from Merck Darmstadt, Germany .
2.2. Preparation of liposomes
The formulations used in this study are presented
in Table 1. Lipids andror surfactant were dissolved
 .in dichloromethane: methanol 3:1 and the lipophilic
 .fluorescent marker Fl-DHPE was added to achieve
 .Fig. 1. CLSM images of a cross-section of human skin treated with fluorescent-labelled liposomes. DLPC:C EO 60:40 , DLPC:C EO12 7 12 7
 .  .  .82:18 or DSPC:CHEMS 82:18 liposomes were non-occlusively applied to the skin for 3 or 6 h. In Fig. 1b, stratum corneum SC ,
 .  .  .viable epidermis E , dermis D and remaining suspension S are indicated.
( )M.E.M.J. ˝an Kuijk-Meuwissen et al.rBiochimica et Biophysica Acta 1371 1998 31–3934
 .a final molar concentration of 2.75%. The solvent
was evaporated in a vacuum centrifuge Speed Vac
.Concentrator, Savant, Dunee, Soest, NL . The lipid
film was hydrated with HEPES buffer at pHs7.4
 .20 mM HEPES, 135 mM NaCl in a sonication bath
 .Transonic 460rH, Elma, Singen, Germany at room
temperature, except the DSPC:CHEMS liposomes,
which were prepared above the transition temperature
 .)568C . The final lipid concentration of the lipo-
somes was 50 mgrml. The size and polydispersity
were determined by dynamic light scattering Malvern
.4700C, Malvern Instruments, Malvern, UK . The
measurements were performed at 278C at an angle of
908 between laser and detector. The mean sizes and
polydispersity indices are summarized in Table 1.
Mixing of C EO with Fl-DHPE resulted in the12 7
formation of vesicles, instead of micelles; therefore,
Fl-C was used as a single chain fluorescent marker18
in the micelles.
2.3. Application of liposomes on human skin, in ˝itro
Human abdomen skin was obtained after cosmetic
surgery. After removal of the subcutaneous fat, the
skin was dermatomed to a thickness of 200–250 mm
 .Padgett Dermatome, Kansas City, USA . The skin
was placed in Franz-type diffusion cells. The accep-
tor compartment was filled, till 3 mm below the
dermal surface of the skin, with HEPES buffer and
kept at 328C. In this way, overhydration of the skin
could be avoided; therefore, the watergradient across
the skin will not be changed. Liposomes were applied
non-occlusively on the stratum corneum side of the
 2.skin 33 mlrcm , except for one experiment in
 .which DLPC:C EO 60:40 liposomes were ap-12 7
plied occlusively, by covering the donor compartment
with a stopper. After 1, 3, 6, and 16 h of application,
the skin surface was rinsed 3 times with HEPES
buffer and was blotted dry with a tissue. The cleaned
skin was cross-sectioned and immediately examined
 .by CLSM see below .
( )2.4. Confocal laser scanning microscopy CLSM
A mechanical cross-section was made from the
liposome-treated skin, with a special designed cross-
w xsection device 19 . The cross-sectioned skin was
mounted in a sample holder in such way that the
freshly obtained cutting surface was positioned against
the cover glass. To avoid interference by fluorescence
from damaged cells, the mechanical cross-section of
the skin was examined by CLSM, 10 mm below the
cutting surface.
The CLSM used was a BioRad MRC 600 confocal
 .unit BioRad, Hertfordshire, UK equipped with a
Krypton–Argon laser and mounted on a Nikon Op-
 .tiphot Nikon, Tokyo, Japan . For excitation of the
probe the 488-nm laser line was used. The fluores-
cein–DHPE or the fluorescein–C was detected us-18
 .ing the BioRad Blue High-Sensitivity BHS fil-
terblock, which passes emitted light with a wave-
length longer than 515 nm. Confocal images were
Fig. 2. Summarized blind scoring data from CLSM pictures.
CLSM images were taken from cross-sections of human skin,
which was non-occlusively incubated with fluorescent-labelled
liposomes or micelles for 1, 3, 6 and 16 h. The images were
scored on depth of label penetration and fluorescence intensities
in stratum corneum, viable epidermis and dermis: y no fluores-
cence; " weak fluorescence; q fluorescence; qq bright fluo-
rescence.
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obtained using a Zeiss Plan Neofluor 25=r0.8
multi-immersion objective, on its oil position. The
images were corrected for autofluorescence of the
skin, with the blacklevel setting. All the pictures were
averages of 10 scans.
2.5. Scoring
For each liposome suspension, skin from at least
two skin donors was used.
The fluorescence intensities of the CLSM pictures
were semi-quantitatively blind-scored by 3 individu-
als and classified as follows: y no fluorescence, "
weak fluorescence, q medium fluorescence and qq
bright fluorescence. At the same time, the number of
cell layers of the viable epidermis that contained
fluorescence was counted and classified in one of
these three categories: 1–2 cell layers, 1–4 cell lay-
ers, complete epidermis. The results of the semi-
quantitatively blind scoring are summarized in Fig. 3.
3. Results
3.1. Comparison between the ˝arious suspensions
In Fig. 1, representative images are shown of skin
incubated for 3 or 6 h with either DLPC:C EO12 7
 .  .60:40 , DLPC:C EO 82:18 or DSPC:CHEMS12 7
liposomes.
The fluorescent label can be detected in the stra-
 .  .tum corneum SC , viable epidermis E and dermis
 .D . Most images have an intense white band on the
left side corresponding to the skin surface. On the
right side, the area is less bright, correlating to the
dermal side of the skin. In some pictures, a striped
structure can be observed, within the white band.
 .Fig. 3. CLSM images of a cross-section of human skin incubated with fluorescent-labelled DLPC:C12EO7 60:40 liposomes. The
liposomes were applied non-occlusively or occlusively for 6 or 16 h.
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This relates to the flattened stratum corneum cells
 .corneocytes that are embedded in lipid lamellae. In
 .Fig. 1c, the individual corneocytes 30 mm can be
observed; the fluorescent label is present around these
flattened cells. In this image also, the viable epider-
mis cells are visualized. In these cells, the fluores-
cence is present in the cell interior, except for the
dark round areas in the centre of the cells, corre-
sponding to the nuclei.
In Fig. 2, the results of the blind scoring are
summarized for each formulation and application pe-
riod. The various liposomes and micelles can be
compared with respect to the penetration depth of the
label and the intensity of the fluorescence in the
various skin layers.
3.2. Occlusi˝e ˝s. non-occlusi˝e application
 .DLPC:C EO 60:40 liposomes were applied oc-12 7
clusively or non-occlusively on human skin. The
fluorescence distribution in the skin after 6 and 16 h
is presented in Fig. 3. While after occlusive applica-
tion the fluorescent label was restricted to the viable
Fig. 4. Summarized blind scoring data from CLSM pictures.
CLSM images were taken from cross-sections of human skin that
was occlusively or non-occlusively incubated with fluorescent-
 .labelled DLPC:C EO 60:40 liposomes for 1, 3, 6 and 16 h.12 7
The images were scored on depth of label penetration and
fluorescence intensities in stratum corneum, viable epidermis and
dermis: y no fluorescence; " weak fluorescence; q fluores-
cence; qq bright fluorescence.
Fig. 5. Optical CLSM sections parallel to the skin surface depict
 ).  .skin wrinkles see . DLPC:C12EO7 82:18 liposomes were
 .non-occlusively applied on the stratum corneum side a , or on
 .the dermal side b of human skin. The hexagon with a diameter
of 30 mm presents a corneocyte.
epidermis, non-occlusive administration revealed the
label in the dermis, already after 6 h. In Fig. 4, the
results of the blind scoring are summarized for each
application period.
( )3.3. Skin wrinkles dermatoglyphics
 .Skin treated with DLPC:C EO 82:18 for 6 h12 7
non-occlusively on the stratum corneum side, was
also examined by CLSM parallel to the skin surface.
Fig. 5a presents such a parallel image, in which very
 ) .bright lines see in Fig. 5a and hexagonal-shaped
 .structures 30 mm , which correspond to the shape of
a corneocytes, can be observed.
Fig. 5b depicts a parallel image of skin on which
the same type of vesicles was applied non-occlu-
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sively on the dermal side of the skin for 6 h. This
image is made on the level of the viable epidermis
and shows fluorescence around these small cells. In
 ) .addition, black wide lines see in Fig. 5b can be
observed, and they have a similar contour as the
white lines shown in Fig. 5a. These lines most proba-
bly correspond to skin wrinkles.
4. Discussion
4.1. Comparison between gel-state and liquid-state
liposomes
 .At skin temperature 328C , DSPC:CHEMS form
gel-state liposomes and consequently have very rigid
bilayers, while DLPC:CHEMS liposomes are in the
liquid-state. The latter were prepared from phospho-
lipids with a shorter chain length than the phospho-
lipids in the gel-state vesicles. Therefore, these lipo-
somes were used to study the effect of the thermody-
namic state of the bilayers on the penetration of the
label into the skin.
The label incorporated in the gel-state
DSPC:CHEMS liposomes did not penetrate as deep
into the skin as when it was applied in the liquid-state
DLPC:CHEMS liposomes. Only after 6 h application
of the gel-state vesicles a small amount of the dye
could be detected in the dermis, while during all
other application periods, the label did not penetrate
further than the viable epidermis.
From these observations, it can be concluded that
the penetration of the label is strongly influenced by
the thermodynamic state of the liposomal bilayer.
4.2. Comparison between the ˝arious liquid-state li-
posomes
In two liquid-state liposomes, a single chain sur-
factant, C EO , was incorporated to achieve more12 7
w xdeformable bilayers 18,20 . Two DLPC:C EO sus-12 7
pensions with different molar ratios were used.
The penetration profiles of the label applied in the
 .various DLPC suspensions were very similar Fig. 2 .
 .Application of the label in DLPC:C EO 60:4012 7
liposomes resulted in a slightly higher fluorescence
intensity in the skin compared to application of the
 . label in DLPC:C EO 82:18 all application peri-12 7
.ods and the conventional DLPC:CHEMS liposomes
 .6 and 16 h . From this, it was concluded that
intercalation of a surfactant in the liposomal bilayer,
which increased the flexibility of this bilayer Van
.Kuijk-Meuwissen et al., unpublished data , does not
result in a dramatic increase of penetration of the
fluorescent label into human skin.
This is in contrast with the CLSM results, reported
w xby Schatzlein and Cevc 18 . They concluded that the¨
label originally intercalated in transfersomese pene-
trated much further into murine skin than the label
applied in conventional liposomes. The differences in
findings between the former experiments and the
 .present study may be due to i different composition
 .of the vesicles, ii differences in the skin tissue
murine stratum corneum consists only of 5–6 cell
layers, while human stratum corneum contains 20–30
.  .cell layers , or iii difference between in vitro and in
vivo. However, we also carried out in vivo experi-
ments with rats Van Kuijk-Meuwissen et al., unpub-
.lished data . In these studies, a very similar label
distribution was observed as in the present investiga-
tion.
4.3. Comparison between micelles and liquid-state
˝esicles
The effect on label penetration of pure C EO ,12 7
forming micelles in the buffer solution, was also
studied in order to assess if the C EO micelles can12 7
increase the penetration of the label in the skin to the
same extent as the DLPC:C EO suspensions, or12 7
that the presence of vesicles is responsible for the
increase in penetration of the label.
Skin treated with micelles revealed a much weaker
fluorescence intensity than skin incubated with DLPC
liposomes. These findings are in agreement with
w xthose published before 18 , in which also a lower
label penetration into the skin after application of
micelles has been reported, despite the smaller size of
micelles.
The present findings are also in agreement with
earlier studies where the estradiol flux through stra-
w xtum corneum was investigated, in vitro 21 . In these
studies, it was found that estradiol-loaded vesicles
resulted in a higher estradiol flux compared to estra-
diol-loaded micelles.
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It seems that the vesicular bilayer form is more
favourable than a micellar form for increasing the
penetration depth of the fluorescent label in the skin.
4.4. Occlusi˝e ˝s. non-occlusi˝e application
The fluorescent dye distribution after occlusive
application was compared to non-occlusive applica-
tion. In these experiments, we chose for the
 .DLPC:C EO 60:40 suspension, since this suspen-12 7
sion revealed the highest fluorescence intensity in the
deeper layers of the skin. From Figs. 3 and 4, it is
clear that large differences in fluorescence intensity
are observed in favour of the non-occlusive method.
These results are in agreement with the theory that
the natural transepidermal water activity gradient acts
as a strong driving force to get substances across the
w xskin barrier 17,20 . During occlusive application, the
water gradient is expected to be absent.
4.5. Skin wrinkles
Fig. 5a shows fluorescence in between the
hexagons and Fig. 1c also reveals fluorescence in the
intercellular spaces. From this, it can be concluded
that the fluorescent label, applied in the liposomal
bilayer, penetrates the stratum corneum mainly via
w xthe intercellular route. Cevc et al. 17 also described
this route. In the same study also, a second type of
passage through the skin was described, namely wide
clefts between clusters of 3–10 corneocytes with a
w xwidth of G0.1 mm 17 . In Fig. 5a of this paper,
 ) .similar wide lines are depicted see in Fig. 5a . In
our experiments, these regions are filled with fluores-
cent material, due to pooling of the liposome suspen-
sion. We strongly have the impression that these lines
correspond to wrinkles in the skin. This means that
the fluorescent label detected in these regions is still
on the surface of the skin. The fact that these lines
remained dark after application of the same vesicle
suspension on the dermal side of the skin see Fig.
.5b confirms this suggestion.
4.6. Intact liposome penetration?
CLSM does not provide reliable information about
the question whether or not liposomes can penetrate
as intact vesicles, because only the fluorescent marker
is visualized and not the entire liposome. There are at
least three mechanisms by which the label can pene-
 .trate the skin: i the label penetrates associated with
 .  .the intact liposomal bilayer intact liposome , ii the
label penetrates solitary liposomal phospholipids
.  .penetrate molecularly dispersed or iii the label
penetrates associated with liposomal bilayer frag-
 .ments after disruption of the liposomes .
One way to distinguish intact liposomes from dis-
rupted ones is using two fluorescent labels suitable
 .for resonance energy transfer RET , and to interca-
late both labels in the liposomal bilayers. In our
experiments for this purpose, fluorescein–DHPE
 .  .donor and Texas Red–DHPE acceptor were used.
That both labels penetrated via the same intercellular
route was anticipated, since they both are lipophilic.
In an ideal RET experiment, all the emission light
from fluorescein would be absorbed by Texas Red;
thus, only the fluorescence from Texas Red would be
detected. In the case that also disrupted liposomes are
present, not only fluorescence from Texas Red, but
also from the fluorescein label will be observed.
However, we were not able to incorporate both labels
in such concentrations, that only the fluorescence of
Texas Red was detected by dual CLSM imaging of
the liposomes, and without disturbing the physical
properties of the vesicles. Therefore, with the set-up
of these CLSM experiments, no final answer can be
given about the state in which liposomes are able to
penetrate the human skin.
5. Conclusions
From the present results, it can be concluded that
both the vesicular form and the thermodynamic state
 .of liposomes play an important role in trans dermal
penetration of model compounds. A lipophilic sub-
stance penetrates deeper into the skin when it is
applied in liquid-state liposomes than when it is
applied in gel-state vesicles. A high deformability of
the liposomal bilayer resulted in a slightly better
penetration of the lipophilic probe compared to con-
ventional liposomes. In addition, non-occlusive appli-
cation resulted in deeper penetration of the label into
the skin than occlusive application. Furthermore, it
should be stated that CLSM does not provide reliable
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information about the question whether or not lipo-
somes can penetrate as intact vesicles.
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